These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 33259961)

  • 1. Nanoparticles target intimal macrophages in atherosclerotic lesions.
    Dhanasekara CS; Zhang J; Nie S; Li G; Fan Z; Wang S
    Nanomedicine; 2021 Feb; 32():102346. PubMed ID: 33259961
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of atherosclerotic lesions and intimal macrophages using CD36-targeted nanovesicles.
    Nie S; Zhang J; Martinez-Zaguilan R; Sennoune S; Hossen MN; Lichtenstein AH; Cao J; Meyerrose GE; Paone R; Soontrapa S; Fan Z; Wang S
    J Control Release; 2015 Dec; 220(Pt A):61-70. PubMed ID: 26450668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-atherogenic effects of CD36-targeted epigallocatechin gallate-loaded nanoparticles.
    Zhang J; Nie S; Zu Y; Abbasi M; Cao J; Li C; Wu D; Labib S; Brackee G; Shen CL; Wang S
    J Control Release; 2019 Jun; 303():263-273. PubMed ID: 30999008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Formulation, characteristics and antiatherogenic bioactivities of CD36-targeted epigallocatechin gallate (EGCG)-loaded nanoparticles.
    Zhang J; Nie S; Martinez-Zaguilan R; Sennoune SR; Wang S
    J Nutr Biochem; 2016 Apr; 30():14-23. PubMed ID: 27012617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Native and modified low density lipoproteins increase the functional expression of the macrophage class B scavenger receptor, CD36.
    Han J; Hajjar DP; Febbraio M; Nicholson AC
    J Biol Chem; 1997 Aug; 272(34):21654-9. PubMed ID: 9261189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel family of atherogenic oxidized phospholipids promotes macrophage foam cell formation via the scavenger receptor CD36 and is enriched in atherosclerotic lesions.
    Podrez EA; Poliakov E; Shen Z; Zhang R; Deng Y; Sun M; Finton PJ; Shan L; Febbraio M; Hajjar DP; Silverstein RL; Hoff HF; Salomon RG; Hazen SL
    J Biol Chem; 2002 Oct; 277(41):38517-23. PubMed ID: 12145296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Salvianolic acid B inhibits macrophage uptake of modified low density lipoprotein (mLDL) in a scavenger receptor CD36-dependent manner.
    Bao Y; Wang L; Xu Y; Yang Y; Wang L; Si S; Cho S; Hong B
    Atherosclerosis; 2012 Jul; 223(1):152-9. PubMed ID: 22658257
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EP 80317, a ligand of the CD36 scavenger receptor, protects apolipoprotein E-deficient mice from developing atherosclerotic lesions.
    Marleau S; Harb D; Bujold K; Avallone R; Iken K; Wang Y; Demers A; Sirois MG; Febbraio M; Silverstein RL; Tremblay A; Ong H
    FASEB J; 2005 Nov; 19(13):1869-71. PubMed ID: 16123174
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD36 is a receptor for oxidized low density lipoprotein.
    Endemann G; Stanton LW; Madden KS; Bryant CM; White RT; Protter AA
    J Biol Chem; 1993 Jun; 268(16):11811-6. PubMed ID: 7685021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of a novel family of oxidized phospholipids that serve as ligands for the macrophage scavenger receptor CD36.
    Podrez EA; Poliakov E; Shen Z; Zhang R; Deng Y; Sun M; Finton PJ; Shan L; Gugiu B; Fox PL; Hoff HF; Salomon RG; Hazen SL
    J Biol Chem; 2002 Oct; 277(41):38503-16. PubMed ID: 12105195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rosuvastatin restores superoxide dismutase expression and inhibits accumulation of oxidized LDL in the aortic arch of obese dyslipidemic mice.
    Verreth W; De Keyzer D; Davey PC; Geeraert B; Mertens A; Herregods MC; Smith G; Desjardins F; Balligand JL; Holvoet P
    Br J Pharmacol; 2007 Jun; 151(3):347-55. PubMed ID: 17384667
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD36-dependent 7-ketocholesterol accumulation in macrophages mediates progression of atherosclerosis in response to chronic air pollution exposure.
    Rao X; Zhong J; Maiseyeu A; Gopalakrishnan B; Villamena FA; Chen LC; Harkema JR; Sun Q; Rajagopalan S
    Circ Res; 2014 Oct; 115(9):770-780. PubMed ID: 25186795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD36 modulates migration of mouse and human macrophages in response to oxidized LDL and may contribute to macrophage trapping in the arterial intima.
    Park YM; Febbraio M; Silverstein RL
    J Clin Invest; 2009 Jan; 119(1):136-45. PubMed ID: 19065049
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IRGM1 regulates oxidized LDL uptake by macrophage via actin-dependent receptor internalization during atherosclerosis.
    Xia F; Li R; Wang C; Yang S; Tian L; Dong H; Pei C; He S; Jiang P; Cheng H; Fang S; Li H; Xu H
    Sci Rep; 2013; 3():1867. PubMed ID: 23689639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vav Guanine nucleotide exchange factors regulate atherosclerotic lesion development in mice.
    Rahaman SO; Li W; Silverstein RL
    Arterioscler Thromb Vasc Biol; 2013 Sep; 33(9):2053-7. PubMed ID: 23825362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resident intimal dendritic cells accumulate lipid and contribute to the initiation of atherosclerosis.
    Paulson KE; Zhu SN; Chen M; Nurmohamed S; Jongstra-Bilen J; Cybulsky MI
    Circ Res; 2010 Feb; 106(2):383-90. PubMed ID: 19893012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Macrophage-specific lipid-based nanoparticles improve cardiac magnetic resonance detection and characterization of human atherosclerosis.
    Lipinski MJ; Frias JC; Amirbekian V; Briley-Saebo KC; Mani V; Samber D; Abbate A; Aguinaldo JG; Massey D; Fuster V; Vetrovec GW; Fayad ZA
    JACC Cardiovasc Imaging; 2009 May; 2(5):637-47. PubMed ID: 19442953
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Curcumin modulation of high fat diet-induced atherosclerosis and steatohepatosis in LDL receptor deficient mice.
    Hasan ST; Zingg JM; Kwan P; Noble T; Smith D; Meydani M
    Atherosclerosis; 2014 Jan; 232(1):40-51. PubMed ID: 24401215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeted Nanotherapeutics Encapsulating Liver X Receptor Agonist GW3965 Enhance Antiatherogenic Effects without Adverse Effects on Hepatic Lipid Metabolism in Ldlr
    Yu M; Amengual J; Menon A; Kamaly N; Zhou F; Xu X; Saw PE; Lee SJ; Si K; Ortega CA; Choi WI; Lee IH; Bdour Y; Shi J; Mahmoudi M; Jon S; Fisher EA; Farokhzad OC
    Adv Healthc Mater; 2017 Oct; 6(20):. PubMed ID: 28730752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oxidized LDL-bound CD36 recruits an Na⁺/K⁺-ATPase-Lyn complex in macrophages that promotes atherosclerosis.
    Chen Y; Kennedy DJ; Ramakrishnan DP; Yang M; Huang W; Li Z; Xie Z; Chadwick AC; Sahoo D; Silverstein RL
    Sci Signal; 2015 Sep; 8(393):ra91. PubMed ID: 26350901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.